Jennifer A. Getz

High-Affinity, Stable Peptide Ligands Engineered from a Kalata B1 Knottin Library

Jennifer A. Getz, 2012 .

Identifi cation of protease exosite-interacting peptides that enhance substrate cleavage kinetics

Jennifer A. Getz, J. Hardy, P. Daugherty, 2012, Biological chemistry.

Protease-resistant peptide ligands from a knottin scaffold library.

Patrick S Daugherty, Jennifer A. Getz, Jeffrey J. Rice, 2011, ACS chemical biology.

A Novel Quantitative Kinase Assay Using Bacterial Surface Display and Flow Cytometry

Jennifer A. Getz, D. Craik, Yen‐Hua Huang, 2013, PloS one.

EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY

Tina N. Davis, Forrest M Kievit, Atique U. Ahmed, 2013 .

Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases.

Jennifer A. Getz, E. Ruoslahti, P. Daugherty, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation

Adam P. Silverman, Jennifer A. Getz, D. Holtzman, 2018, The Journal of clinical investigation.

Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice

Adam P. Silverman, Jennifer A. Getz, Michelle L. Reyzer, 2020, Science Translational Medicine.

Neutropenia in Cynomolgus Monkeys With Anti-Drug Antibodies Associated With Administration of Afucosylated Humanized Monoclonal Antibodies

Jennifer A. Getz, W. Halpern, A. Adedeji, 2022, Toxicologic pathology.

Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys

Adam P. Silverman, Jennifer A. Getz, T. Miyamoto, 2020, Science Translational Medicine.

Design of a cyclotide antagonist of neuropilin-1 and -2 that potently inhibits endothelial cell migration.

Jennifer A. Getz, D. Craik, O. Cheneval, 2013, ACS chemical biology.